Phathom Pharmaceuticals, Inc. ( PHAT) - Stock Earnings
PHAT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -21.1 million USD | 57.6 million USD |
| 2026Q1 | -30.4 million USD | 58.3 million USD |
| 2026Q2 | -17.6 million USD | 74.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
PHAT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -201.6 million USD | 682000 USD |
| 2024 | -334.3 million USD | 55.3 million USD |
| 2025 | -221.2 million USD | 175.1 million USD |
| 2026 Est. | — | — |
PHAT
Price: $9.57
52 week price:
Earnings Per Share: -1.22 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 521200
Market Capitalization: 665.8 million